Merck gets unanimous vote for FDA backing of Bridion
After several setbacks, Merck & Co has finally achieved an important milestone to securing FDA approval for its muscle relaxant reversal agent Bridion.
After several setbacks, Merck & Co has finally achieved an important milestone to securing FDA approval for its muscle relaxant reversal agent Bridion.